Abstract
Objective
Multi-drug
resistance
(MDR)
has
notably
increased
in
community
acquired
uropathogens
causing
urinary
tract
infections
(UTIs),
predominantly
Escherichia
coli
.
Uropathogenic
E.
causes
80%
of
uncomplicated
UTIs,
particularly
pre-menopausal
women.
Considering
this
high
prevalence
and
the
potential
to
spread
antimicrobial
resistant
genes,
current
study
was
conducted
investigate
presence
clinically
important
strains
Pakistani
women
having
cystitis
pyelonephritis.
Women
belonging
low-income
groups
were
exclusively
included
study.
Seventy-four
isolates
from
urine
samples
processed,
phylotyped,
screened
for
two
Single
Nucleotide
Polymorphisms
(SNPs)
associated
with
a
clonal
group
A
(CgA)
followed
by
antibiotic
susceptibility
testing
genome
sequence
analysis.
Results
Phylogroup
B2
most
prevalent
patients
44%
positive
CgA
specific
SNPs
Fumarate
hydratase
DNA
gyrase
subunit
B
genes.
Antibiotic
showed
widespread
trimethoprim-sulfamethoxazole
extended-spectrum
beta-lactamase
production.
The
infection
analysis
revealed
phylogroup
be
more
pathogenic
as
compared
other
groups.
strain
U17
genes
encoding
virulence,
multidrug
resistance,
host
colonization
mechanisms.
Conclusions
Our
research
findings
not
only
validate
significant
occurrence
multidrug-resistant
premenopausal
suffering
pyelonephritis
but
also
reveal
withvirulence,
drug
efflux
pumps.
detection
highly
pathogenic,
antimicrobial-resistant
is
likely
help
understanding
epidemiology
pathogen
may
ultimately
reduce
impact
these
on
human
health.
Furthermore,
will
UTIs
cost
their
treatment
Healthcare,
Год журнала:
2023,
Номер
11(13), С. 1946 - 1946
Опубликована: Июль 5, 2023
Antibiotics
are
among
the
most
important
discoveries
of
20th
century,
having
saved
millions
lives
from
infectious
diseases.
Microbes
have
developed
acquired
antimicrobial
resistance
(AMR)
to
many
drugs
due
high
selection
pressure
increasing
use
and
misuse
antibiotics
over
years.
The
transmission
acquisition
AMR
occur
primarily
via
a
human–human
interface
both
within
outside
healthcare
facilities.
A
huge
number
interdependent
factors
related
agriculture
govern
development
through
various
drug-resistance
mechanisms.
emergence
spread
unrestricted
antimicrobials
in
livestock
feed
has
been
major
contributing
factor.
prevalence
antimicrobial-resistant
bacteria
attained
an
incongruous
level
worldwide
threatens
global
public
health
as
silent
pandemic,
necessitating
urgent
intervention.
Therapeutic
options
infections
caused
by
limited,
resulting
significant
morbidity
mortality
with
financial
impact.
paucity
discovery
supply
new
novel
treat
life-threatening
resistant
pathogens
stands
sharp
contrast
demand.
Immediate
interventions
contain
include
surveillance
monitoring,
minimizing
over-the-counter
food
animals,
access
quality
affordable
medicines,
vaccines
diagnostics,
enforcement
legislation.
An
orchestrated
collaborative
action
between
multiple
national
international
organizations
is
required
urgently,
otherwise,
postantibiotic
era
can
be
more
real
possibility
than
apocalyptic
fantasy
for
21st
century.
This
narrative
review
highlights
on
this
basis,
mechanisms
microbial
resistance,
key
strategies
combat
resistance.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(11), С. 1615 - 1615
Опубликована: Ноя. 15, 2023
Antibiotics
have
revolutionized
medicine,
saving
countless
lives
since
their
discovery
in
the
early
20th
century.
However,
origin
of
antibiotics
is
now
overshadowed
by
alarming
rise
antibiotic
resistance.
This
global
crisis
stems
from
relentless
adaptability
microorganisms,
driven
misuse
and
overuse
antibiotics.
article
explores
subsequent
emergence
It
delves
into
mechanisms
employed
bacteria
to
develop
resistance,
highlighting
dire
consequences
drug
including
compromised
patient
care,
increased
mortality
rates,
escalating
healthcare
costs.
The
elucidates
latest
strategies
against
drug-resistant
encompassing
innovative
approaches
such
as
phage
therapy,
CRISPR-Cas9
technology,
exploration
natural
compounds.
Moreover,
it
examines
profound
impact
resistance
on
development,
rendering
pursuit
new
economically
challenging.
limitations
challenges
developing
novel
are
discussed,
along
with
hurdles
regulatory
process
that
hinder
progress
this
critical
field.
Proposals
for
modifying
facilitate
development
presented.
withdrawal
major
pharmaceutical
firms
research
examined,
potential
re-engage
interest.
also
outlines
initiatives
overcome
economic
incentivize
emphasizing
international
collaborations
partnerships.
Finally,
sheds
light
government-led
a
specific
focus
Middle
East.
discusses
proactive
measures
taken
governments
region,
Saudi
Arabia
United
Arab
Emirates,
combat
threat.
In
face
multifaceted
approach
imperative.
provides
valuable
insights
complex
landscape
challenges,
collaborative
efforts
required
ensure
future
where
remain
effective
tools
safeguarding
public
health.
Antibiotics
are
the
most
magnificent
discovery
of
20th
century
that
have
saved
millions
lives
from
infectious
diseases.
Microbes
developed
acquired
antimicrobial
resistance
(AMR)
to
many
drugs
due
high
selection
pressure
increasing
use
and
misuse
antibiotics
over
years.
The
transmission
acquisition
AMR
occur
primarily
via
human–human
interface
both
within
outside
healthcare
facilities.
A
huge
number
interdependent
factors
related
agriculture
govern
development
through
various
drug
mechanisms.
emergence
spread
unrestricted
antimicrobials
in
livestock
feed
has
been
a
major
contributing
factor.
prevalence
bacteria
attained
its
incongruous
level
worldwide
threatening
global
public
health
as
silent
pandemic,
necessitating
urgent
intervention.
Therapeutic
options
bacterial
infections
limited
resulting
significant
morbidity
mortality
with
financial
impact.
paucity
supply
new
novel
treat
life-threatening
stands
sharp
contrast
demand.
Immediate
interventions
contain
include
surveillance
monitoring,
minimizing
counter
food
animals,
access
quality
affordable
medicines,
vaccines
diagnostics,
enforcement
legislation.
An
orchestral
collaborative
action
between
multiple
national
international
organizations
required
urgently,
otherwise,
post-antibiotic
era
can
be
real
possibility
than
an
apocalyptic
fantasy
for
21st
century.
This
narrative
review
highlights
on
basis,
mechanisms
microbial
key
strategies
combat
resistance.
Plants,
Год журнала:
2024,
Номер
13(4), С. 504 - 504
Опубликована: Фев. 11, 2024
Plant
by-products,
which
are
discarded
into
the
environment,
rich
in
valuable
compounds.
The
aim
of
this
research
was
to
determine
antibacterial
activity
Rubus
idaeus
L.
morphological
parts
and
its
correlation
with
total
phenolic
content
antioxidant
activity.
authors
also
aimed
evaluate
plant’s
potential
as
added-value
products.
New
aspects
were
revealed
for
further
use
making
novel
natural
study’s
results
indicated
that
raspberry
leaves,
inflorescences,
fruits
could
effectively
combat
three
Gram-positive
bacteria.
According
findings,
among
various
plant
parts,
root
seed
extracts
had
lowest
Data
moderate,
weak,
or
very
weak
between
antimicrobial
parameters.
These
findings
underscore
viability
substituting
synthetic
antimicrobials
alternatives.
present
study
is
significant
preparing
products
antibacterials
by
appropriate
optimized
processing
using
all
show
promising
prospects
future
purposeful
utilisation
nature-based
Raspberry
can
find
applications
emerging
fields
generate
economic
environmental
value.
Microbial Cell Factories,
Год журнала:
2025,
Номер
24(1)
Опубликована: Янв. 5, 2025
Abstract
Carbapenem-resistant
Klebsiella
pneumoniae
poses
a
severe
risk
to
global
public
health,
necessitating
the
immediate
development
of
novel
therapeutic
strategies.
The
current
study
aimed
investigate
effectiveness
green
algae
Arthrospira
maxima
(commercially
known
as
Spirulina
)
both
in
vitro
and
vivo
against
carbapenem-resistant
K.
.
In
this
study,
thirty
isolates
were
collected,
identified,
then
screened
for
their
susceptibility
several
antibiotics
carbapenemase
production
genes
using
PCR.
Both
bla
KPC
OXA-48
most
predominant
detected
tested
isolates.
phytochemical
profiling
A.
algal
extract
was
conducted
LC–MS/MS
positive
mode
technique.
minimum
inhibitory
concentrations
(MIC)
ranged
from
500
1000
µg/mL.
also
resulted
decreasing
membrane
integrity
distortion
bacterial
cells
revealed
by
scanning
electron
microscope.
bioactive
compounds
that
responsible
antibacterial
action
fatty
acids,
including
PUFAs,
polysaccharides,
glycosides,
peptides,
flavonoids,
phycocyanin,
minerals,
essential
amino
vitamins.
Moreover,
an
antibiofilm
activity
crystal
violet
assay
qRT-PCR.
A
murine
pneumonia
model
employed
assessment
extract.
showed
promising
which
comparable
colistin
(standard
drug).
This
manifested
improving
pulmonary
architecture,
inflammatory
cell
infiltration,
fibrosis
after
staining
with
hematoxylin
eosin
Masson’s
trichrome
stain.
Using
immunohistochemical
investigations,
percentage
immunoreactive
significantly
decreased
monoclonal
antibodies
tumor
necrosis
factor-alpha
interleukin
six.
So,
may
be
considered
new
candidate
medications.
Graphical
Microorganisms,
Год журнала:
2023,
Номер
11(4), С. 945 - 945
Опубликована: Апрель 4, 2023
Nosocomial
bacterial
and
fungal
infections
are
one
of
the
main
causes
high
morbidity
mortality
worldwide,
owing
to
prevalence
multidrug-resistant
microbial
strains.
Hence,
study
aims
synthesize,
characterize,
investigate
antifungal
antibacterial
activity
silver
nanoparticles
(AgNPs)
fabricated
using
Camellia
sinensis
leaves
against
nosocomial
pathogens.
The
biogenic
AgNPs
revealed
a
small
particle
diameter
35.761
±
3.18
nm
based
on
transmission
electron
microscope
(TEM)
graphs
negative
surface
charge
-14.1
mV,
revealing
repulsive
forces
between
nanoparticles,
which
in
turn
indicated
their
colloidal
stability.
disk
diffusion
assay
confirmed
that
Escherichia
coli
was
most
susceptible
strain
(200
g/disk),
while
lowest
sensitive
found
be
Acinetobacter
baumannii
with
relative
inhibition
zones
36.14
0.67
21.04
0.19
mm,
respectively.
On
other
hand,
µg/disk)
exposed
efficacy
Candida
albicans
zone
18.16
0.14
mm
diameter.
synergistic
both
tigecycline
clotrimazole
A.
C.
albicans,
In
conclusion,
demonstrated
distinct
physicochemical
properties
potential
bioactivity
tigecycline,
linezolid,
gram-negative,
gram-positive,
strains,
This
is
paving
way
for
development
effective
antimicrobial
combinations
management
pathogens
intensive
care
units
(ICUs)
health
settings.
Biomedicines,
Год журнала:
2023,
Номер
11(10), С. 2605 - 2605
Опубликована: Сен. 22, 2023
Antimicrobial
resistance
is
considered
a
"One-Health"
problem,
impacting
humans,
animals,
and
the
environment.
The
problem
of
rapid
development
spread
bacteria
resistant
to
multiple
antibiotics
rising
global
health
threat
affecting
both
rich
poor
nations.
Low-
middle-income
countries
are
at
highest
risk,
in
part
due
lack
innovative
research
on
surveillance
discovery
novel
therapeutic
options.
Fast
effective
drug
crucial
towards
combatting
antimicrobial
reducing
burden
infectious
diseases.
African
medicinal
plants
have
been
used
for
millennia
folk
medicine
cure
many
diseases
ailments.
Over
10%
Southern
vegetation
applied
traditional
medicine,
with
over
15
species
being
partially
or
fully
commercialized.
These
include
genera
Antibiotics,
Год журнала:
2024,
Номер
13(2), С. 121 - 121
Опубликована: Янв. 25, 2024
The
development
of
antimicrobial
resistance
(AMR),
along
with
the
relative
reduction
in
production
new
antimicrobials,
significantly
limits
therapeutic
options
infectious
diseases.
Thus,
novel
treatments,
especially
current
era,
where
AMR
is
increasing,
are
urgently
needed.
There
several
ongoing
studies
on
non-classical
therapies
for
diseases,
such
as
bacteriophages,
peptides,
and
nanotechnology,
among
others.
Nanomaterials
involve
materials
nanoscale
that
could
be
used
diagnosis,
treatment,
prevention
This
review
provides
an
overview
applications
nanotechnology
diagnosis
treatment
diseases
from
a
clinician’s
perspective,
focus
pathogens
AMR.
Applications
nanomaterials
by
taking
advantage
their
electrochemical,
optic,
magnetic,
fluorescent
properties,
described.
Moreover,
potential
metallic
or
organic
nanoparticles
(NPs)
infections
also
addressed.
Finally,
use
NPs
safe
efficient
vaccines
reviewed.
Further
needed
to
prove
safety
efficacy
would
facilitate
approval
regulatory
authorities
clinical
use.